Q/C Technologies, Inc. (QCLS)
0.50
0.00 (0.00%)
USD |
NASDAQ |
Oct 20, 16:00
0.52
+0.02
(+4.00%)
After-Hours: 06:35
Q/C Technologies Net Income (Quarterly) : -6.616M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -6.616M |
| March 31, 2026 | -1.243M |
| December 31, 2025 | -5.895M |
| September 30, 2025 | -2.811M |
| June 30, 2025 | -1.796M |
| March 31, 2025 | -1.125M |
| December 31, 2024 | -2.064M |
| September 30, 2024 | -1.929M |
| June 30, 2024 | -9.566M |
| March 31, 2024 | -9.80M |
| December 31, 2023 | -2.364M |
| September 30, 2023 | 4.043M |
| June 30, 2023 | -4.168M |
| March 31, 2023 | -1.512M |
| December 31, 2022 | -3.746M |
| September 30, 2022 | -3.694M |
| June 30, 2022 | -3.636M |
| March 31, 2022 | -4.122M |
| December 31, 2021 | -3.240M |
| September 30, 2021 | -5.467M |
| June 30, 2021 | -18.09M |
| March 31, 2021 | -3.090M |
| December 31, 2020 | -3.106M |
| September 30, 2020 | -2.916M |
| June 30, 2020 | -1.095M |
| Date | Value |
|---|---|
| March 31, 2020 | -3.534M |
| December 31, 2019 | -0.6782M |
| September 30, 2019 | -0.8208M |
| June 30, 2019 | -0.7949M |
| March 31, 2019 | -0.917M |
| December 31, 2018 | -3.838M |
| September 30, 2018 | -3.084M |
| June 30, 2018 | -2.068M |
| March 31, 2018 | -1.86M |
| December 31, 2017 | -4.021M |
| September 30, 2017 | -1.178M |
| June 30, 2017 | -0.818M |
| March 31, 2017 | -1.349M |
| December 31, 2016 | -1.096M |
| September 30, 2016 | 0.3102M |
| June 30, 2016 | -1.009M |
| March 31, 2016 | -1.509M |
| December 31, 2015 | -3.577M |
| September 30, 2015 | -2.327M |
| June 30, 2015 | -2.086M |
| March 31, 2015 | -1.322M |
| December 31, 2014 | -0.9123M |
| September 30, 2014 | -1.124M |
| June 30, 2014 | -0.495M |
| March 31, 2014 | -0.5956M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 23.00M |
| Corcept Therapeutics, Inc. | 42.14M |
| Veru, Inc. | -6.988M |
| Johnson & Johnson | 210.00M |
| Eli Lilly & Co. | 7.095B |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 6.616M |
| EPS Diluted (Quarterly) | -0.794 |
| Enterprise Value | -3.393M |
| Earnings Yield | -868.0% |
| Normalized Earnings Yield | -683.22 |